(Q38919922)

7 September 2017

Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity (English)

1 reference

7 September 2017

1 reference

Yan-Dong Tang

1

1 reference

7 September 2017

Lei Na

2

1 reference

7 September 2017

Li-Hua Fu

3

1 reference

7 September 2017

Fei Yang

4

1 reference

7 September 2017

Chun-Hui Zhu

5

1 reference

7 September 2017

Li Tang

6

1 reference

7 September 2017

Qiang Li

7

1 reference

7 September 2017

Jia-Yi Wang

8

1 reference

7 September 2017

Zhan Li

9

1 reference

7 September 2017

Xue-Feng Wang

10

1 reference

7 September 2017

Cheng-Yao Li

11

1 reference

7 September 2017

Xiaojun Wang

12

1 reference

7 September 2017

Jian-Hua Zhou

13

1 reference

7 September 2017

language of work or name

English

0 references

publication date

9 January 2015

1 reference

7 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

7 September 2017

476

1 reference

7 September 2017

364-371

1 reference

RNA editing by adenosine deaminases that act on RNA

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

ADAR1 is a novel multi targeted anti-HIV-1 cellular protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Biased hypermutation and other genetic changes in defective measles viruses in human brain infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Multiple levels of PKR inhibition during HIV-1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Activation of PKR: an open and shut case?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Biased mutational pattern and quasispecies hypothesis in H5N1 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Functions and regulation of RNA editing by ADAR deaminases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Innate immune sensing and signaling of cytosolic nucleic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2014.12.038

1 reference

7 September 2017

1 reference